TrialBlood advances2025
Nivolumab and rituximab in treatment-naïve follicular lymphoma: the phase 2 1st FLOR study.
Allison Barraclough et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papertrialcites it
TrialBlood advances2025
Allison Barraclough et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.